Tom Rodgers
Executive Vice President & Chief Strategy and Business Development Officer
Tom Rodgers is Executive Vice President and Chief Strategy and Business Development Officer for McKesson Corporation. As a member of the Executive Operating Team, Tom oversees McKesson’s growth strategy, acquisitions and venture investments.
With more than 25 years of experience leading emerging companies and working in large healthcare environments, Tom has served in a variety of leadership roles at McKesson. Prior to his current role, he led the launch and successful scaling of McKesson’s Venture fund and led strategy for McKesson’s pharmaceutical distribution business. Previously, Tom served as Director of Strategic Investments at Cambia Health and was a partner at Advanced Technology Ventures, where he led the fund’s investments in healthcare technology. Earlier in his career, Tom served in roles at Genentech, Fitlinxx, IBM and The Wilkerson Group.
Tom’s investments and board experience spans numerous innovative companies across the healthcare landscape, including Accolade, Zeltiq, Aperio, Hims, Aetion, Helixis, Grail, Carena, Kyruus, and OncoHealth.
Tom holds a bachelor’s degree from the University of Pennsylvania and a Master of Business Administration from the Wharton School.